Table 2 Selected down-regulated genes after 24 h drug exposure, with log2 FC values across all datasets, from RNA-seq analyses.

From: Structure–activity relationships for the G-quadruplex-targeting experimental drug QN-302 and two analogues probed with comparative transcriptome profiling and molecular modeling

Functional relevance, gene name

SOP1247 in MIA- PaCa2

CM03 in

MIA- PaCa2

CM03 in

MIA- PaCa2-GemR

CM03 in

PANC-1

QN-302 in MIA-PaCa2

PQs

Hedgehog pathway

 GLI1

 − 0.13

0.03

 − 0.57

 − 0.57

 − 1.84

15

 GLI2

 − 0.74

 − 1.24

0.00

0.38

 − 0.15

71

 GLI3

2.63

 − 0.58

0.00

0.28

 − 0.47

13

 GLI4

 − 2.67

 − 1.26

 − 2.76

 − 1.71

 − 0.90

11

WNT pathway

 WNT5B

 − 0.66

 − 0.97

0.34

 − 0.01

 − 0.58

8

 DVL1

 − 1.87

 − 1.35

 − 2.68

 − 1.56

 − 0.77

30

 AXIN1

 − 0.92

 − 0.72

 − 1.35

 − 0.74

 − 0.39

18

 APC2

 − 3.20

 − 1.61

 − 3.17

 − 1.62

 − 1.06

4

Axon guidance

 PAK1

 − 1.39

 − 1.13

 − 1.74

 − 1.11

 − 0.22

14

 ROBO3

0.08

 − 0.53

 − 1.09

 − 0.85

0.23

19

 PLXNA1

 − 1.62

 − 1.56

 − 2.55

 − 1.50

 − 0.92

54

 NTN4

3.47

4.04

N/A

0.95

 − 2.46

13

Hippo pathway

 TAZ

 − 0.88

 − 1.10

 − 1.49

 − 0.74

 − 0.56

8

 TEAD2

 − 0.52

 − 0.91

 − 0.37

0.21

 − 0.61

19

 TEAD3

 − 0.14

 − 0.66

 − 0.33

0.07

 − 0.43

29

 TEAD4

 − 0.50

 − 0.31

 − 0.77

 − 0.04

 − 0.13

34

 SHANK2

 − 2.4

 − 1.96

N/A

 − 0.44

 − 0.37

203

 SHANK3

 − 1.34

 − 0.85

 − 0.95

 − 1.12

 − 0.11

42

Transcriptional genes

 PRDM16

 − 3.88

 − 3.39

 − 3.48

 − 3.14

 − 1.91

260

 TP73

 − 1.49

 − 1.19

 − 2.37

 − 0.99

 − 0.61

91

 CBFA2T3

 − 2.90

 − 2.86

 − 3.32

 − 2.24

 − 1.50

96

 MYC

 − 0.02

0.34

0.71

0.71

 − 0.07

4

Chemokines

 CX3CL1

 − 1.08

 − 1.82

N/A

0.62

 − 2.91

5

 CXCL1

 − 2.90

 − 1.38

 − 1.38

 − 1.69

 − 1.37

1

Signal transduction pathways

 KRAS

0.22

 − 0.15

 − 0.17

0.05

 − 0.10

4

 MAPK11

 − 2.12

 − 2.56

 − 3.03

 − 1.59

 − 1.72

18

 MAPK12

 − 1.11

 − 1.23

 − 0.68

 − 1.44

 − 0.70

18

 AKT1

 − 1.20

 − 0.98

 − 1.55

 − 1.04

 − 0.37

44

 ARF6

 − 0.99

 − 0.54

 − 0.99

 − 0.69

 − 0.22

7

 IQSEC1

 − 0.79

 − 0.53

 − 0.80

 − 0.50

 − 0.20

82

Transporters

 SLC19A1

 − 4.70

 − 3.94

 − 5.25

 − 2.05

 − 2.27

38

 SLC29A1

 − 0.49

 − 0.16

 − 0.60

 − 0.15

 − 0.17

25

 CLIC3

1.05

0.92

N/A

 − 0.29

 − 2.77

6

Misc function

 HSPA1A

 − 0.21

 − 0.12

 − 0.46

0.01

 − 1.15

3

 BCL2

 − 1.76

 − 1.24

 − 1.82

N/A

 − 0.48

21

 hTERT

 − 3.32

 − 2.47

 − 4.21

 − 0.98

 − 1.03

15

 S100P

 − 0.53

N/A

1.47

N/A

 − 3.23

60

 RTN4R

 − 2.87

 − 2.23

 − 2.77

 − 1.85

 − 1.87

28

 KRT16

 − 4.06

 − 

 − 

0.56

 − 1.98

2

  1. PQs represent the estimated number of putative quadruplex-forming sequences, taken from40,41,42.